Premium
Monotherapy versus combined androgen blockade in patients with advanced prostate cancer
Author(s) -
Errejon Abelardo,
Crawford E. David
Publication year - 2002
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.10648
Subject(s) - medicine , blockade , prostate cancer , androgen , urology , randomized controlled trial , oncology , androgen suppression , clinical trial , prostate , gynecology , cancer , hormone , receptor
Despite a number of large randomized clinical trials, there still is uncertainty regarding the value of maximal androgen blockade in the treatment of patients with advanced prostate carcinoma. In the referenced article, the authors provide a very comprehensive review of the literature concerning one of the most controversial issues in contemporary urology.See also pages 361–76.